Clinical trial
A Study of the Effectiveness of Fampridine in Improving Upper Limb Function in MS
NCT02208050
Study timeline
Study start (actual)2014-02-21Date precision: day
Registry last updated2021-07-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Secondary Progressive Multiple Sclerosisunresolved
Primary Progressive Multiple Sclerosisunresolved
Interventions
FampridineDRUG · verified · RxNorm: dalfampridine
PlaceboDRUG
Sponsors & collaborators
University College Dublinlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02208050 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.